Obesity may have an adverse effect on the outcome of laparoscopic antireflux surgery (LARS).
In this study, investigators from St Louis, Missouri, compared 505 obese and nonobese patients undergoing LARS, between 1992 and 2001.
The team surveyed patients preoperatively and then annually after the procedure.
|Operative time was longer in obese patients.|
Patients completed questionnaires querying symptoms and overall satisfaction.
Of the 505 patients 16% were of normal weight, 42% were overweight, and 42% were obese.
The investigators found that the operative time was longer in the obese patients (137 mins) than in the normal weight patients (55 mins). However, the time to discharge and complications rate was the same in the 2 groups.
Furthermore, after a mean follow-up of 35 months, there were no differences in symptoms, overall improvement, or patient satisfaction.
The team determined that the rate of anatomic failure was similar between the 3 groups.
Dr Winslow's team concluded, "Although the operative time is longer in the obese, complication and anatomic failure rates are similar to those in the nonobese at long-term follow-up".
"Obese patients have equivalent symptom relief and are equally satisfied postoperatively".
"Therefore, obesity should not be a contraindication to LARS".